Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is > 10% Shareholder of Verve Therapeutics, Inc.. Currently has a direct ownership of 2.5 Million shares of VERV, which is worth approximately $12.1 Million. The most recent transaction as insider was on Jun 21, 2021, when has been sold 2,495,571 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.5M
0% 3M change
0% 12M change
Total Value Held $12.1 Million

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2021
BUY
Conversion of derivative security
-
2,495,571 Added 50.0%
2,495,571 Common Stock

Also insider at

NUVL
Nuvalent, Inc. Healthcare
EWTX
Edgewise Therapeutics, Inc. Healthcare
OLMA
Olema Pharmaceuticals, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
RTVA
Artiva Biotherapeutics, Inc.
ACRV
Acrivon Therapeutics, Inc.
BOLD
Boundless Bio, Inc.
ZBIO
Zenas BioPharma, Inc.
WBI

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on VERV

Follow Verve Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERV shares.

Notify only if

Insider Trading

Get notified when an Verve Therapeutics, Inc. insider buys or sells VERV shares.

Notify only if

News

Receive news related to Verve Therapeutics, Inc.

Track Activities on VERV